Clinical trials
Completed Phase 2 Adenoma, Islet Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dana-Farber Cancer Institute | 2 |
| H. Lee Moffitt Cancer Center and Research Institute | 2 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2 |
| Aadi Bioscience, Inc. | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| ECOG-ACRIN Cancer Research Group | 1 |
| Eastern Cooperative Oncology Group | 1 |
| Endeavor Biomedicines, Inc. | 1 |
| Federation Francophone de Cancerologie Digestive | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenoma, Islet Cell | 18 |
| Gastrinoma | 7 |
| Carcinoma, Islet Cell | 6 |
| Glucagonoma | 6 |
| Insulinoma | 6 |
| Neuroendocrine Tumors | 6 |
| Somatostatinoma | 6 |
| Carcinoid Tumor | 5 |
| Neoplasm Metastasis | 4 |
| Neoplasms | 4 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.